ADALIMUMAB

adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes

ADALIMUMAB (13228F)

adalimumab 40 mg/0.4 mL injection, 2 x 0.4 mL syringes
13228F
Body System:
Manner of administration:Injection
Public
S100 HSD Public
Authority Required (STREAMLINED)

Restriction  17707

Indication: Severe active juvenile idiopathic arthritis
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 1 Max qty units: 2 # of repeats: 5 DPMQ: $444.17 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Hadlima
Humira
Hyrimoz
Yuflyma